Phenomic AI is accelerating drug discovery with AI.

Our founding team consists of PhDs who pioneered the application of deep learning to biological imaging screens and chemo-informatics. The combination of machine learning technologies and phenotypic screening (a holistic approach to drug discovery) has the potential to unlock key discoveries that will greatly advance medicine in the next decade. Phenomic AI is leading this revolution in drug discovery.